Your Global CRO Partner In Ophthalmology

Ophthalmic drug and device development demands precision, agility, and deep therapeutic knowledge. With over 70 successfully completed ophthalmology studies across rare and common conditions, TFS brings unmatched insight into front- and back-of-the-eye diseases, including inherited retinal disorders, uveitis, and age-related macular degeneration. TFS also offers comprehensive support across all phases, including adaptive trial design, biomarker-guided strategies, regulatory expertise in combination products, and seamless integration with imaging and diagnostic partners. Whether optimizing protocol design, managing site logistics, or executing global recruitment strategies, we understand the nuances that make ophthalmology trials distinct. Whether you're a biotech pioneering innovation or a pharma sponsor scaling your pipeline, TFS is the strategic partner to deliver results and bring impactful ophthalmic therapies to patients worldwide. Discover how our focused ophthalmology expertise can support your next clinical breakthrough.